Involvement of the L-DOPA receptor GPR143 in acute and chronic actions of methylphenidate
Methylphenidate (MPH) and methamphetamine (METH) are the current treatments of choice for attention deficit/hyperactivity disorder. We previously reported that METH induces the release of dopamine (DA) and of the neurotransmitter candidate L-3,4-dihydroxyphenylalanine (L-DOPA). In contrast, we here...
Main Authors: | Hiraku Uchimura, Kaori Kanai, Masami Arai, Miyu Inoue, Akitoyo Hishimoto, Daiki Masukawa, Yoshio Goshima |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-07-01
|
Series: | Journal of Pharmacological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861323000282 |
Similar Items
-
l-3,4-Dihydroxyphenylalanine induces ptosis through a GPR143-independent mechanism in mice
by: Suguru Ueda, et al.
Published: (2016-09-01) -
Genetic associations of single nucleotide polymorphisms in the l-DOPA receptor (GPR143) gene with severity of nicotine dependence in Japanese individuals, and attenuation of nicotine reinforcement in Gpr143 gene-deficient mice
by: Daiki Masukawa, et al.
Published: (2020-10-01) -
Right ventricular overloading is attenuated in monocrotaline-induced pulmonary hypertension model rats with a disrupted Gpr143 gene, the gene that encodes the 3,4-l-dihydroxyphenyalanine (l-DOPA) receptor
by: Masayuki Nakano, et al.
Published: (2022-02-01) -
l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson’s Disease
by: Yoshio Goshima, et al.
Published: (2019-10-01) -
Differences of ocular oscillations and neuro-retinal structures in patients with nystagmus caused by GPR143 and FRMD7 gene variants
by: Lijuan Huang, et al.
Published: (2024-04-01)